Drug Shortage Report for ISOFLURANE USP

Last updated on 2024-08-10 History
Report ID 234160
Drug Identification Number 02231929
Brand name ISOFLURANE USP
Common or Proper name ISOFLURANE USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ISOFLURANE
Strength(s) 99.9%
Dosage form(s) LIQUID
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 250 mL
ATC code N01AB
ATC description ANESTHETICS, GENERAL
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2024-07-30
Estimated end date 2024-08-28
Actual end date 2024-08-09
Shortage status Resolved
Updated date 2024-08-10
Company comments Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on the below Isoflurane USP 99.9% product formats effective July 30, 2024, until August 28, 2024.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-08-10 English Compare
v4 2024-08-09 French Compare
v3 2024-08-09 English Compare
v2 2024-07-31 French Compare
v1 2024-07-31 English Compare

Showing 1 to 5 of 5